Breaking News, Collaborations & Alliances

Flare Teams Up with Roche for Cancer Drug Discovery

Will leverage Flare Therapeutics’ proteomic & mass spectrometry platform to discover novel small molecules aimed at transcription factor targets in oncology.

Author Image

By: Charlie Sternberg

Associate Editor

Flare Therapeutics Inc., a clinical-stage biotechnology company targeting transcription factors to discover precision medicines for oncology and other therapeutic areas, has entered into a strategic discovery collaboration with Roche.   This partnership will leverage Flare Therapeutics’ proteomic and mass spectrometry platform and expertise, powered by its proprietary library of electrophilic compounds, to discover novel small molecule drugs aimed at previously undrugged transcription factor t...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters